GLP-1 drug adherence and patient satisfaction are poor, with 80% of patients wanting to reduce or discontinue them.

80% of Virta Health patients on GLP-1s report wanting to severely reduce dependence on those drugs or get off them completely.

“80% of them say I either want to severely reduce the dependence on these drugs or get completely awful.”

As of approximately May 2026, total GLP-1 drug revenue was greater than the combined total revenue of all AI labs.

“Up until I think 3 months ago right GLP1's like total revenue was more than all of the AI labs put.”

Adherence of Virta Health patients to the program at one year is twice as high as adherence to GLP-1 drugs.

“The adherence of verta patients again which are like real Americans not sis real Americans is twice as high at one year as taking a JB1 drug.”